Xenetic Biosciences, Inc. XBIO 深 沪
等待开盘 03-27 09:30:00 美东时间
2.82
-0.170
-5.69%
华盛通- 最 高2.9842
- 今 开2.94
- 成交量 8979股
- 最 低 2.81
- 昨 收 2.99
- 总市值 646.08万
- 52周最高 13.93
- 市盈率 静 --
- 换手率 0.39%
- 52周最低 1.90
- 委 比 6.10%
- 总股本 229.11万
- 历史最高 1074.00
- 量 比 0.98
- 振 幅 5.83%
- 历史最低 1.90
- 每 手 1
- 风险率 0.87%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Xenetic Biosciences reports FY results
Xenetic Biosciences press release (XBIO): FY Net loss for the year ended December 31, 2025 was approximately $2.7 million, reflecting investment in the Company's most promising scientific programs. R...
03-14 03:26
Xenetic Biosciences Q4 EPS $(0.22) Beats $(0.52) Estimate, Sales $766.296K Beat $690.000K Estimate
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.52) by 57.69 percent. This is a 67.65 percent increase over losses of $(0.68) per share
03-13 20:11
Xenetic Biosciences faces ongoing delays in annual meeting
An update from Xenetic Biosciences ( ($XBIO) ) is now available. On December 11...
01-10 06:15
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
Xenetic Biosciences Executes 4-Month Extension Of Collaboration With Institute Investigator At Scripps Research To Advance Development Of R&D Program Evaluating Combination Of Systemic Dnase I And CAR T-Cell Therapies
Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced it has
2025-11-19 21:47
Xenetic Biosciences Q3 EPS $(0.33) Beats $(0.49) Estimate, Sales $1.027M Beat $630.000K Estimate
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.49) by 32.65 percent. This is a 17.86 percent decrease over losses of $(0.28) per share
2025-11-13 21:49
Xenetic Biosciences Announces Public Offering Pricing
Xenetic Biosciences ( ($XBIO) ) has provided an announcement. On October 10, 20...
2025-10-14 21:21
Xenetic Biosciences Prices Offering Of 735K Common Shares At $6.12/Shr For Gross Proceeds Of ~$4.5M
Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced the
2025-10-10 21:33
Xenetic Biosciences Announces 45 Million Underwritten Offering of Common Stock
Xenetic Biosciences Inc. has announced the pricing of an underwritten offering of 735,000 shares of common stock at $6.12 per share, totaling approximately $4.5 million in gross proceeds before deduct...
2025-10-10 21:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock moved upwards by 137.1% to $10...
2025-10-09 01:06
